0.2927
price down icon0.10%   -0.0003
after-market After Hours: .29 -0.0027 -0.92%
loading
Spruce Biosciences Inc stock is traded at $0.2927, with a volume of 885.99K. It is down -0.10% in the last 24 hours and down -17.78% over the past month.
See More
Previous Close:
$0.293
Open:
$0.285
24h Volume:
885.99K
Relative Volume:
2.40
Market Cap:
$12.09M
Revenue:
$7.10M
Net Income/Loss:
$-39.43M
P/E Ratio:
-0.3114
EPS:
-0.94
Net Cash Flow:
$-46.50M
1W Performance:
-7.81%
1M Performance:
-17.78%
6M Performance:
-33.48%
1Y Performance:
-64.47%
1-Day Range:
Value
$0.2626
$0.2966
1-Week Range:
Value
$0.26
$0.3179
52-Week Range:
Value
$0.26
$0.87

Spruce Biosciences Inc Stock (SPRB) Company Profile

Name
Name
Spruce Biosciences Inc
Name
Phone
(415) 655-4168
Name
Address
611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
2025-03-31
Name
Latest SEC Filings
Name
SPRB's Discussions on Twitter

Compare SPRB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
SPRB
Spruce Biosciences Inc
0.2927 12.09M 7.10M -39.43M -46.50M -0.94
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 124.29B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 68.39B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 35.99B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.93B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.47B 3.81B -644.79M -669.77M -6.24

Spruce Biosciences Inc Stock (SPRB) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-11-24 Downgrade JMP Securities Mkt Outperform → Mkt Perform
Dec-11-24 Downgrade Oppenheimer Outperform → Perform
Mar-14-24 Downgrade Guggenheim Buy → Neutral
Mar-14-24 Downgrade H.C. Wainwright Buy → Neutral
Mar-14-24 Downgrade Ladenburg Thalmann Buy → Neutral
Mar-14-24 Downgrade Leerink Partners Outperform → Market Perform
Mar-14-24 Downgrade RBC Capital Mkts Outperform → Sector Perform
Feb-21-24 Initiated Guggenheim Buy
Dec-17-21 Initiated Oppenheimer Outperform
Dec-10-21 Initiated The Benchmark Company Speculative Buy
Nov-16-21 Downgrade SVB Leerink Outperform → Mkt Perform
Jul-19-21 Initiated H.C. Wainwright Buy
Apr-26-21 Resumed Credit Suisse Outperform
Nov-03-20 Initiated Cowen Outperform
Nov-03-20 Initiated Credit Suisse Outperform
Nov-03-20 Initiated RBC Capital Mkts Outperform
Nov-03-20 Initiated SVB Leerink Outperform
View All

Spruce Biosciences Inc Stock (SPRB) Latest News

pulisher
Apr 01, 2025

Spruce Biosciences reports delayed annual filing By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Spruce Biosciences reports delayed annual filing - Investing.com

Apr 01, 2025
pulisher
Mar 31, 2025

Spruce Biosciences Delays Annual Report Filing - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Layoff Tracker: Arbutus Cuts 57% of Workforce - BioSpace

Mar 31, 2025
pulisher
Mar 31, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Mar 31, 2025
pulisher
Mar 25, 2025

Spruce Biosciences stock hits 52-week low at $0.32 - Investing.com

Mar 25, 2025
pulisher
Mar 25, 2025

In-Depth Analysis Of The Global Congenital Adrenal Hyperplasia Market: Key Drivers, Trends, Growth Opportun... - WhaTech

Mar 25, 2025
pulisher
Mar 22, 2025

SPRUCE BIOSCIENCES INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com

Mar 22, 2025
pulisher
Mar 20, 2025

Invivyd, Inc. (IVVD) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Mar 20, 2025
pulisher
Mar 14, 2025

Analysts Set Spruce Biosciences, Inc. (NASDAQ:SPRB) PT at $2.38 - Defense World

Mar 14, 2025
pulisher
Mar 12, 2025

SPRB Stock Touches 52-Week Low at $0.34 Amid Steep Decline - Investing.com India

Mar 12, 2025
pulisher
Mar 11, 2025

Agenus (AGEN) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Mar 11, 2025
pulisher
Mar 05, 2025

Spruce Biosciences (SPRB) to Release Quarterly Earnings on Wednesday - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Harbour Biomed newco HBM Alpha pens $395M hyperplasia drug deal - BioWorld Online

Mar 04, 2025
pulisher
Mar 04, 2025

SPRB stock touches 52-week low at $0.34 amid sharp annual decline - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Short Interest in Kingsoft Co. Limited (OTCMKTS:KSFTF) Increases By 79.4% - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Archer-Daniels-Midland Company (NYSE:ADM) Receives Consensus Rating of “Reduce” from Brokerages - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Traws Pharma, Inc. (NASDAQ:TRAW) Short Interest Update - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Spruce Biosciences, Inc. (NASDAQ:SPRB) Short Interest Up 81.4% in February - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

SPRB stock touches 52-week low at $0.34 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 03, 2025
pulisher
Feb 28, 2025

Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 21, 2025

Spruce Biosciences, Inc. (SPRB) Reports Q2 Loss, Tops Revenue Estimates - MSN

Feb 21, 2025
pulisher
Feb 18, 2025

NeoGenomics (NEO) Tops Q4 Earnings Estimates - Yahoo Finance

Feb 18, 2025
pulisher
Feb 17, 2025

The Prothena Corporation plc (PRTA) had a good session last reading, didn’t it? - US Post News

Feb 17, 2025
pulisher
Feb 17, 2025

Element Solutions Inc (NYSE:ESI) Receives $30.14 Consensus Price Target from Analysts - Defense World

Feb 17, 2025
pulisher
Feb 17, 2025

Alamos Gold Inc. (TSE:AGI) Receives C$28.78 Average Target Price from Brokerages - Defense World

Feb 17, 2025
pulisher
Feb 17, 2025

Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives $3.90 Consensus Target Price from Analysts - Defense World

Feb 17, 2025
pulisher
Feb 10, 2025

Spruce Biosciences Inc [SPRB] Investment Appeal on the Rise - Knox Daily

Feb 10, 2025
pulisher
Feb 08, 2025

Spruce Biosciences Inc (NASDAQ: SPRB) Stock Has Gained 4.05% Over The Month – Is There Room For Growth? - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 08, 2025

Should You Expect Akero Therapeutics Inc (NASDAQ:AKRO) To Recover From Its 70.02% Gain From Highs? - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 08, 2025

Five Point Holdings LLC (NYSE: FPH): Can The Stock Still Lose Despite An 54.23% YTD Gain? - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 07, 2025

Why you might not want to use AI to spruce up your job application - Yahoo

Feb 07, 2025
pulisher
Feb 04, 2025

Spruce Biosciences Inc (SPRB) Stock Price and Analyst Predictions - The News Heater

Feb 04, 2025
pulisher
Feb 04, 2025

Spruce Biosciences Inc (NASDAQ:SPRB) stock: You might be surprised - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

Examining OppFi Inc (OPFI) stock is warranted - US Post News

Feb 04, 2025
pulisher
Jan 27, 2025

(PDF) Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials - ResearchGate

Jan 27, 2025
pulisher
Jan 23, 2025

Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives $3.90 Consensus Target Price from Brokerages - Defense World

Jan 23, 2025
pulisher
Jan 23, 2025

After A 1.47% Jump In The Last Week, Does Amprius Technologies Inc (NYSE: AMPX) Still Make Sense To Buy? - Marketing Sentinel

Jan 23, 2025

Spruce Biosciences Inc Stock (SPRB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Cap:     |  Volume (24h):